Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Eliminates hundreds of treatments! Pfizer (PFE.US) gene therapy approved for listing by FDA
Pfizer/PFE.us (Pfizer/PFE.us) announced that the US FDA has approved the single-use gene therapy Beqvez (fidanacogene elaparvovec) it has developed to treat adults with moderate to severe hemophilia B aged 18 or above.
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
Jim Cramer, the host of CNBC's "Mad Money," has outlined the key events that investors should keep an eye on in the upcoming week.What Happened: Cramer highlighted the significant events scheduled for
Preview -- Barron's
Tuesday 4/30 It's the busiest week of first-quarter earnings season, as more than 150 S&P 500 index companies are scheduled to publish their results. Advanced Micro Devices, Amazon.com, Eli Lilly, an